Pharmacology, Toxicology and Pharmaceutical Science
Kidney Disease
60%
Aztreonam
50%
Pharmacokinetics
50%
Meropenem
50%
Rituximab
50%
Urokinase Receptor
50%
Disease Severity
50%
Infection
50%
Peritoneal Dialysis Fluid
50%
Peripheral Occlusive Artery Disease
50%
Minimum Inhibitory Concentration
35%
Dialysis Fluid
28%
2,5-Dimethoxy-4-iodoamphetamine
20%
Chronic Kidney Failure
15%
Infectious Agent
14%
Antimicrobial Agent
14%
Icodextrin
14%
Peritonitis
14%
Troleandomycin
10%
Creatinine
8%
Glucocorticoid
7%
Pharmacodynamics
7%
Pharmacokinetic Modeling
7%
High Performance Liquid Chromatography
7%
Antibiotics
7%
Pseudomonas aeruginosa
7%
Escherichia coli
7%
Sclerosis
5%
Enzyme-Linked Immunosorbent Assay
5%
All Cause Mortality
5%
Albumin
5%
Cardiovascular Risk
5%
Immunology and Microbiology
Artery
100%
Rituximab
50%
Peritoneal Dialysis
50%
Galectin 3
50%
Urinary Excretion
50%
Infection
50%
Autoimmunity
50%
Urokinase Receptor
50%
Antimicrobial Agent
33%
Antimicrobial Activity
33%
Disk Diffusion
16%
High Performance Liquid Chromatography
16%
Escherichia coli
16%
Peritonitis
16%
Pseudomonas aeruginosa
16%
All Cause Mortality
13%
Ankle
9%
Glomerulus Filtration
9%
Limb
8%
Kidney Function
7%
Glucocorticoid
6%
Albumin
5%
ELISA
5%
Nursing and Health Professions
Peripheral Occlusive Artery Disease
50%
Disease Severity
50%
Galectin 3
50%
Creatinine
12%
All Cause Mortality
8%
Chronic Kidney Failure
8%
Critical Limb Ischemia
8%
Albumin
5%
